Rockefeller University
Clinical trials sponsored by Rockefeller University, explained in plain language.
-
Can antibodies keep HIV in check after stopping meds?
Disease control CompletedThis early-stage study tested whether giving two lab-made antibodies (3BNC117 and 10-1074) to people with HIV could safely control the virus after they stopped their regular antiretroviral therapy. Twenty-six adults with well-controlled HIV took part. The goal was to see if these…
Phase: PHASE1 • Sponsor: Rockefeller University • Aim: Disease control
Last updated May 17, 2026 11:34 UTC
-
HIV treatment pause study tests antibody cocktail plus immune booster
Disease control CompletedThis study tested whether a combination of two long-acting antibodies (3BNC117-LS and 10-1074-LS) plus an immune-boosting drug (N-803) can safely control HIV in people who temporarily stop their regular antiretroviral therapy. 28 adults with well-controlled HIV took part. The goa…
Phase: PHASE1 • Sponsor: Rockefeller University • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Compassion training eases racism stress in small pilot study
Symptom relief CompletedThis study tested a 10-week compassion-based training program to help African Americans deal with stress caused by racism. 22 adults took part, learning mindfulness and self-compassion techniques. The goal was to see if the program was practical and helpful for reducing psycholog…
Phase: NA • Sponsor: Rockefeller University • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC
-
Antibiotics may temporarily wipe out gut nerve cells, small study suggests
Knowledge-focused CompletedThis study looked at how a single course of antibiotics changes the nerve and support cells in the lower gut of healthy adults. Ten participants provided colon tissue samples before and after taking antibiotics. The goal was to see if the loss of gut bacteria caused by antibiotic…
Phase: PHASE4 • Sponsor: Rockefeller University • Aim: Knowledge-focused
Last updated May 17, 2026 11:38 UTC